Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

About Apogee Therapeutics

Founded in 2022, Apogee Therapeutics, Inc. is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally.

Apogee Therapeutics, Inc. is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications with high unmet need. Our antibody programs are designed to potentially overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. We seek to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment, and we refuse to stop at “good enough.”

We are a fast-paced company committed to building an exceptional company culture, founded on our C.O.R.E. values: Caring, Original, Resilient and Egoless.

If this sounds like you, keep reading!

Role Summary

We are seeking an R&D System Analyst to join our growing IT Enterprise Applications team. This role will directly support R&D functions (including Clinical Operations, Clinical Development, Quality, Regulatory, and Biometrics) by driving system/business process optimization, managing system change controls, and supporting computer system validation (CSV) activities in a GxP-regulated environment. This role is centered around applications and tools used to oversee and document clinical trials, as well as the processes to collate and submit to health authority agency(s).

This role will serve as a key partner to both IT and R&D business stakeholders, ensuring our enterprise applications meet operational needs and regulatory requirements. This position reports to the Associate Director, GxP R&D Systems within the IT Enterprise Applications team and plays a critical role in the lifecycle management of R&D systems such as Veeva Vault and other cloud-based applications.

Key Responsibilities

System & Business Process Analysis

  • Partner with business teams to define business process(es) & user requirements
  • Support definition of project scope and deliverables to support business goals
  • Identities and troubleshoots technical and system/process issues to resolution
  • Provide training/orientation/qualification to internal users when required

Change Control & Release Management

  • Oversee vendor managed services resources
  • Act as a liaison across R&D teams to ensure the highest level of quality customer service and product delivery

CSV & Compliance

  • Participate in the authoring/review and execution of implementation plans/qualification tests
  • Participate in the authoring/review of computerized system validation (CSV) documentation
  • Execute and coordinate UAT cycles across GxP systems

System Administration and Enhancements

  • Support enhancements, triage requests and backlog management
  • Deliver solutions focused on establishing and improving business processes that improve efficiency, address process gaps, and enable automation and growth of the organization
  • Ensure assignment and timely resolution of account requests, user issues and change requests
  • Liaise with computer system vendors, IT partners, Validation and the business to coordinate implementation activities

Ideal Candidate

  • Bachelor’s degree (or equivalent professional experience) in Life Sciences, Information Systems, Engineering, or related field.
  • 5+ years of experience supporting IT systems or business processes in a biotech, pharmaceutical, or regulated life science environment.
  • Direct hands-on experience implementing technical solutions (workflows, reports/dashboa

Skills

R&D Systems Analysis
IT Enterprise Applications
Clinical Operations
Clinical Development
Quality Assurance
Regulatory Affairs
Biometrics
System Optimization
Business Process Optimization
System Change Control Management
Computer System Validation (CSV)
GxP-regulated environment
Clinical Trial Management Systems
Health Authority Submissions

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI